Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy
Not Applicable
Not yet recruiting
- Conditions
- Bell Palsy
- Interventions
- Drug: Corticosteroid
- Registration Number
- NCT06213415
- Lead Sponsor
- Assiut University
- Brief Summary
intratympanic steroid injection bell's palsy
- Detailed Description
Role of oral steroid alone versus oral steroid plus intratympanic steroid injection in Bell's palsy
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
-
Mean Aged 18 years or more.
- Acute unilateral facial palsy without skin lesions which developed within a 72-hour period and is present for 21 days or less.
- Moderate to severe facial palsy [House-Brackmann grade IV or greater]
Exclusion Criteria
-
Another cause of facial nerve paralysis that is not idiopathic.
- Otologic disease including otitis media, temporal bone fracture, a previous history of facial nerve palsy in either side, history of otologic surgery, and suspected Ramsay Hunt syndrome.
- Systemic disease including history of tuberculosis, history of head and neck cancer, other neurological disorders, recent use of ototoxic medications, liver or renal dysfunction, and other illnesses that would contraindicate the use of high-dose steroid therapy.
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Oral steroids Corticosteroid Oral steroids only Oral steroids plus intratympanic injections Corticosteroid Oral steroids plus intratympanic injections
- Primary Outcome Measures
Name Time Method Success or failure of procedure to treat Bell's palsy 6 months Degree of regaining function to facial nerve Unit of measurement : nerve conduction study
Measurement tool :endoscopic injection by ear microscope
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie corticosteroid efficacy in Bell's Palsy pathophysiology?
How does intratympanic corticosteroid delivery compare to systemic administration in facial nerve inflammation?
What biomarkers correlate with treatment response in Bell's Palsy patients receiving combined corticosteroid therapy?
What are the safety profiles of intratympanic steroid injections versus oral corticosteroids in Bell's Palsy management?
How does combined oral and intratympanic corticosteroid therapy compare to monoclonal antibody approaches in Bell's Palsy treatment?